Nadav Friedmann

Nadav Friedmann

Plus aucun poste en cours
83 ans
Health Technology
Consumer Services
Finance

Profil

Nadav Friedmann served as President & Chief Executive Officer at DaIIchi Pharma Holdings, Inc. from 1997 to 2000.
He also worked as Vice President at Johnson & Johnson from 1980 to 1991 and as Vice President-Clinical Research at XOMA Corp.
from 1992 to 1995.
He was the Director, Chief Operating & Medical Officer at Cassava Sciences, Inc. from 1998 to 2022.
Dr. Friedmann also served as Medical Director at Abbott Laboratories.
He was an Advisor at Presidio Partners and President & Owner at Emet Research, Inc. Dr. Friedmann holds a doctorate degree from the University of California San Diego and Albert Einstein College of Medicine, Inc.

Anciens postes connus de Nadav Friedmann

SociétésPosteFin
FILANA THERAPEUTICS, INC. Directeur Technique/Scientifique/R&D 20/12/2022
Emet Research, Inc.
President 20/12/2022
DaIIchi Pharma Holdings, Inc.
Directeur Général 01/04/2000
XOMA ROYALTY CORPORATION Directeur Technique/Scientifique/R&D 01/01/1995
JOHNSON & JOHNSON Corporate Officer/Principal 01/01/1991
Voir l'expérience en détail de Nadav Friedmann

Formation de Nadav Friedmann

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

71

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Finance

Emet Research, Inc.

DaIIchi Pharma Holdings, Inc.

Consumer Services

  1. Bourse
  2. Insiders
  3. Nadav Friedmann
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇